Skip to content

Psychological Support for Patients With an Implantable Cardioverter Defibrillator

Psychological Support for Patients With an Implantable Cardioverter Defibrillator

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00152763
Enrollment
193
Registered
2005-09-09
Start date
2003-10-31
Completion date
2007-11-30
Last updated
2011-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression

Keywords

health anxiety

Brief summary

About 30% of patients survive a cardiac arrest, and the majority of these receive an implantable cardioverter defibrillator (ICD) for prevention of sudden cardiac death (SCD). While ICD therapy offers survival benefit over drug therapy, there remain significant quality of life (QL) issues. About 50% of patients experience chronic anxiety about receiving an ICD shock. Anxiety and depression in turn appear to predispose to more arrhythmias necessitating ICD therapy. The aims of the current study are: 1. to evaluate a 8-session psychosocial intervention to help patients cope effectively with receiving an ICD for secondary prevention of SCD, 2. to determine if baseline measures of depression and anxiety predict ICD therapies (i.e., anti-tachycardia pace terminations and shocks); and 3. to explore if the psychosocial intervention results in less need for appropriate ICD therapies.

Detailed description

About 30% of patients survive a cardiac arrest, and the majority of these receive an implantable cardioverter defibrillator (ICD) for prevention of sudden cardiac death (SCD). While ICD therapy offers survival benefit over drug therapy, there remain significant quality of life (QL) issues. About 50% of patients experience chronic anxiety about receiving an ICD shock. Anxiety and depression in turn appear to predispose to more arrhythmias necessitating ICD therapy. The aims of the current study are: 1. to evaluate a 8-session psychosocial intervention to help patients cope effectively with receiving an ICD for secondary prevention of SCD, 2. to determine if baseline measures of depression and anxiety predict ICD therapies (i.e., anti-tachycardia pace terminations and shocks); and 3. to explore if the psychosocial intervention results in less need for appropriate ICD therapies. This study will randomize 218 ICD patients to receive either usual cardiac care (n=109) OR usual cardiac care plus CBT (n=109). Participants are recruited from two hospitals in Toronto that perform ICD implants (St. Michael's Hospital and the Toronto General Hospital). Counselling follows a CBT manual and involves both face-to-face sessions and telephone sessions. The telephone is employed as a means to deliver therapy as at least half of our ICD subjects reside outside of Toronto and all patients are prohibited from driving an automobile for the first six months following ICD implant. Outcome is assessed 6 and 12-months following the date of randomization and include measures of psychological function and quality of life. Secondary outcome is frequency of ICD therapies over follow-up (i.e., anti-tachycardia pacing terminations and DC shocks). Inclusion Criteria: * Patients from either Toronto General hospital or St. Michael's Hospital who have coronary heart disease, * Receiving their first ICD implant for secondary prevention of SCD or primary prevention of SCD if their underlying heart disease was hypertrophic cardiomyopathy. Exclusion Criteria: * Not able to read or understand English; * Evidence of psychosis, dementia or cognitive impairment as documented in the patients' hospital records; * Receiving an ICD for primary prevention of ICD.

Interventions

Cognitive behavior therapy tailored to psychological adaptation to an ICD, included 8 telephone counselling sessions, plus psycho-educational booklet and a therapist manual.

OTHERUsual Cardiac Care (UCC)

Usual cardiac care (UCC) was defined as whatever the respective ICD treatment sites routinely offer their patients. All patients received standard educational materials explaining their heart disease and the ICD device. Follow-up appointments include device interrogation (i.e., to extract arrhythmia events and ICD therapies) and trouble-shooting at 6-months intervals, cardiac care as necessary, and nonsystematic supportive reassurance delivered informally in the clinic. Each centre also had access to a cardiac rehabilitation program and psychiatric consultation as needed.

Sponsors

University Health Network, Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients from either Toronto General hospital or St. Michael's Hospital who have coronary heart disease, * Receiving their first ICD implant for secondary prevention of SCD or for primary prevention of SCD and their underlying heart disease was hypertrophic cardiomyopathy.

Exclusion criteria

* Not able to read or understand English; * Evidence of psychosis, dementia or cognitive impairment as documented in the patients' hospital records; * Receiving an ICD for primary prevention of ICD.

Design outcomes

Primary

MeasureTime frameDescription
Crown-Crisp Experiential Index - Phobic Anxiety Scale at 12-months Follow-upTwelve-months follow-upPsychometric measure of phobic anxiety, scores range from 1 to 3. Higher scores represent greater phobic anxiety symptoms.
Impact of Events Scale-Revised - Avoidance Scale at 6-months Follow-upSix-months follow-upPsychometric assessment of post traumatic stress disorder avoidance symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder avoidance symptoms.
Impact of Events Scale-Revised - Avoidance Scale at 12-months Follow-upTwelve-months follow-upPsychometric assessment of post traumatic stress disorder avoidance symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder avoidance symptoms.
Impact of Event Scale-Revised Hyperarousal Scale at BaselineBaselinePsychometric measure of post traumatic stress disorder hyper-arousal symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder hyperarousal symptoms.
Impact of Event Scale-Revised Hyperarousal Scale at 6-months Follow-upSix-months follow-upPsychometric measure of post traumatic stress disorder hyper-arousal symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder hyperarousal symptoms.
Impact of Event Scale-Revised Hyperarousal Scale at 12-months Follow-upTwelve-months follow-upPsychometric measure of post traumatic stress disorder hyper-arousal symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder hyperarousal symptoms.
Crown-Crisp Experiential Index - Phobic Anxiety Scale at BaselineBaselinePsychometric measure of phobic anxiety, scores range from 1 to 3. Higher scores represent greater phobic anxiety symptoms.
Crown-Crisp Experiential Index - Phobic Anxiety Scale at 6-months Follow-upSix-months follow-upPsychometric measure of phobic anxiety, scores range from 1 to 3. Higher scores represent greater phobic anxiety symptoms.
Hospital Anxiety and Depression Scale - Depression Scale at BaselineBaselinePsychometric scale measuring symptoms of depression, score range is 0 to 24. Scores \>= 8 represent clinically elevated scores. Higher scores represent greater depressive symptoms.
Hospital Anxiety and Depression Scale - Depression Scale at 6-months Follow-upSix-months follow-upPsychometric scale measuring symptoms of depression, score range is 0 to 24. Scores \>= 8 represent clinically elevated scores. Higher scores represent greater depressive symptoms.
Hospital Anxiety and Depression Scale - Depression Scale at 12-months Follow-upTwelve-months follow-upPsychometric scale measuring symptoms of depression, score range is 0 to 24. Scores \>= 8 represent clinically elevated scores. Higher scores represent greater depressive symptoms.
Hospital Anxiety and Depression Scale - Anxiety Scale at BaselineBaselinePsychometric scale measuring symptoms of anxiety,score range is 0 to 24. Scores \>= 8 represent clinically elevated scores. Higher scores represent greater anxiety symptoms.
Hospital Anxiety and Depression Scale - Anxiety Scale at 6-months Follow-upSix-months follow-upPsychometric scale measuring symptoms of anxiety,score range is 0 to 24. Scores \>= 8 represent clinically elevated scores. Higher scores represent greater anxiety symptoms.
Hospital Anxiety and Depression Scale - Anxiety Scale at 12-months Follow-upTwelve-months follow-upPsychometric scale measuring symptoms of anxiety,score range is 0 to 24. Scores \>= 8 represent clinically elevated scores. Higher scores represent greater anxiety symptoms.
Impact of Events Scale-Revised - Total Score at BaselineBaselinePsychometric measure of post traumatic stress disorder symptoms, scores range from 0 to 4. A score threshold of 1.4 has been found to diagnostic of post traumatic stress disorder in war veterans. Higher scores represent greater total post traumatic stress disorder symptoms.
Impact of Events Scale-Revised - Total Score at 6-months Follow-upSix-months follow-upPsychometric measure of post traumatic stress disorder symptoms, scores range from 0 to 4. A score threshold of 1.4 has been found to diagnostic of post traumatic stress disorder in war veterans. Higher scores represent greater total post traumatic stress disorder symptoms.
Impact of Events Scale-Revised - Total Score at 12-months Follow-upTwelve-months follow-upPsychometric measure of post traumatic stress disorder symptoms, scores range from 0 to 4. A score threshold of 1.4 has been found to diagnostic of post traumatic stress disorder in war veterans. Higher scores represent greater total post traumatic stress disorder symptoms.
Impact of Events Scale-Revised - Intrusiveness Scale at BaselineBaselinePsychometric measure of post traumatic stress disorder intrusiveness symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder intrusiveness symptoms.
Impact of Events Scale-Revised - Intrusiveness Scale at 6-months Follow-upSix-months follow-upPsychometric measure of post traumatic stress disorder intrusiveness symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder intrusiveness symptoms.
Impact of Events Scale-Revised - Intrusiveness Scale at 12-months Follow-upTwelve-months follow-upPsychometric measure of post traumatic stress disorder intrusiveness symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder intrusiveness symptoms.
Impact of Events Scale-Revised - Avoidance Scale at BaselineBaselinePsychometric assessment of post traumatic stress disorder avoidance symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder avoidance symptoms.

Secondary

MeasureTime frameDescription
SF-36 Mental Component Summary Scale at 6-months Follow-upSix-months follow-upQuality of life measure - mental health summary, scores range from 0 to 100 with higher scores representing better mental health.
SF-36 Mental Component Summary Scale at 12-months Follow-upTwelve-months follow-upQuality of life measure - mental health summary, scores range from 0 to 100 with higher scores representing better mental health.
SF-36 Physical Component Summary Score at BaselineBaselineQuality of life measure of physical health, scores range from 0 to 100 with higher scores representing better physical health.
SF-36 Physical Component Summary Score at 6-months Follow-upSix-months follow-upQuality of life measure of physical health, scores range from 0 to 100 with higher scores representing better physical health.
SF-36 Physical Component Summary Score at 12-months Follow-upTwelve-months follow-upQuality of life measure of physical health, scores range from 0 to 100 with higher scores representing better physical health.
Percentage of Participants Who Received ICD Therapies12-months follow-upPercentage of participants who received ICD shocks or anti-tachycardia therapies, data extracted from participants ICD devices over follow-up.
SF-36 Mental Component Summary Scale at BaselineBaselineQuality of life measure - mental health summary, scores range from 0 to 100 with higher scores representing better mental health.

Countries

Canada

Participant flow

Recruitment details

Recruitment commenced in October 2003 at Toronto General Hospital and St. Michael's Hospital in Toronto, Ontario, Canada and concluded in August 2006.

Pre-assignment details

Upon recruitment, participants completed baseline psychological assessment prior to being randomized to the experimental intervention arm (cognitive behaviour therapy) or usual care.

Participants by arm

ArmCount
Usual Cardiac Care - Men
Cardiac care as usual for the hospital clinic which includesstandard educational materials explaining their heart disease and the ICD device. Follow-up appointments include device interrogation (i.e., to extract arrhythmia events and ICD therapies) and trouble-shooting at 6-months intervals, cardiac care as necessary, and nonsystematic supportive reassurance delivered informally in the clinic. Each centre also had access to a cardiac rehabilitation program and psychiatric consultation as needed.
77
Cognitive Behaviour Therapy - Women
Eight individual sessions of cognitive behaviour therapy delivered via telephone counselling, plus a participant psycho-educational booklet
19
Usual Cardiac Care - Women
Cardiac care as usual which includes standard educational materials explaining their heart disease and the ICD device. Follow-up appointments include device interrogation (i.e., to extract arrhythmia events and ICD therapies) and trouble-shooting at 6-months intervals, cardiac care as necessary, and nonsystematic supportive reassurance delivered informally in the clinic. Each centre also had access to a cardiac rehabilitation program and psychiatric consultation as needed.
20
Cognitive Therapy Group - Men
Eight sessions of individual cognitive therapy delivered via telephone plus a psycho-educational booklet.
77
Total193

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyDeath4121
Overall StudyLost to Follow-up64213

Baseline characteristics

CharacteristicUsual Cardiac Care - MenCognitive Behaviour Therapy - WomenUsual Cardiac Care - WomenCognitive Therapy Group - MenTotal
Age Continuous61.29 years
STANDARD_DEVIATION 13.17
54.58 years
STANDARD_DEVIATION 15.75
55.35 years
STANDARD_DEVIATION 18.3
64.2 years
STANDARD_DEVIATION 13.35
61.68 years
STANDARD_DEVIATION 14.18
Sex: Female, Male
Female
0 Participants19 Participants20 Participants0 Participants39 Participants
Sex: Female, Male
Male
77 Participants0 Participants0 Participants77 Participants154 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
0 / 00 / 00 / 00 / 0
serious
Total, serious adverse events
4 / 771 / 192 / 201 / 77

Outcome results

Primary

Crown-Crisp Experiential Index - Phobic Anxiety Scale at 12-months Follow-up

Psychometric measure of phobic anxiety, scores range from 1 to 3. Higher scores represent greater phobic anxiety symptoms.

Time frame: Twelve-months follow-up

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenCrown-Crisp Experiential Index - Phobic Anxiety Scale at 12-months Follow-up0.98 units on a scaleStandard Deviation 0.4
Cognitive Behaviour Therapy - WomenCrown-Crisp Experiential Index - Phobic Anxiety Scale at 12-months Follow-up1.13 units on a scaleStandard Deviation 0.35
Usual Cardiac Care - WomenCrown-Crisp Experiential Index - Phobic Anxiety Scale at 12-months Follow-up1.07 units on a scaleStandard Deviation 0.4
Cognitive Therapy Group - MenCrown-Crisp Experiential Index - Phobic Anxiety Scale at 12-months Follow-up0.93 units on a scaleStandard Deviation 0.35
Primary

Crown-Crisp Experiential Index - Phobic Anxiety Scale at 6-months Follow-up

Psychometric measure of phobic anxiety, scores range from 1 to 3. Higher scores represent greater phobic anxiety symptoms.

Time frame: Six-months follow-up

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenCrown-Crisp Experiential Index - Phobic Anxiety Scale at 6-months Follow-up0.92 units on a scaleStandard Deviation 0.4
Cognitive Behaviour Therapy - WomenCrown-Crisp Experiential Index - Phobic Anxiety Scale at 6-months Follow-up1.04 units on a scaleStandard Deviation 0.38
Usual Cardiac Care - WomenCrown-Crisp Experiential Index - Phobic Anxiety Scale at 6-months Follow-up1.07 units on a scaleStandard Deviation 0.36
Cognitive Therapy Group - MenCrown-Crisp Experiential Index - Phobic Anxiety Scale at 6-months Follow-up0.84 units on a scaleStandard Deviation 0.35
Primary

Crown-Crisp Experiential Index - Phobic Anxiety Scale at Baseline

Psychometric measure of phobic anxiety, scores range from 1 to 3. Higher scores represent greater phobic anxiety symptoms.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenCrown-Crisp Experiential Index - Phobic Anxiety Scale at Baseline0.98 units on a scaleStandard Deviation 0.39
Cognitive Behaviour Therapy - WomenCrown-Crisp Experiential Index - Phobic Anxiety Scale at Baseline1.17 units on a scaleStandard Deviation 0.28
Usual Cardiac Care - WomenCrown-Crisp Experiential Index - Phobic Anxiety Scale at Baseline1.23 units on a scaleStandard Deviation 0.41
Cognitive Therapy Group - MenCrown-Crisp Experiential Index - Phobic Anxiety Scale at Baseline0.83 units on a scaleStandard Deviation 0.33
Primary

Hospital Anxiety and Depression Scale - Anxiety Scale at 12-months Follow-up

Psychometric scale measuring symptoms of anxiety,score range is 0 to 24. Scores \>= 8 represent clinically elevated scores. Higher scores represent greater anxiety symptoms.

Time frame: Twelve-months follow-up

Population: Intention to treat analyses but data on participants who died over follow-up were omitted.

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenHospital Anxiety and Depression Scale - Anxiety Scale at 12-months Follow-up6.06 units on a scaleStandard Deviation 3.97
Cognitive Behaviour Therapy - WomenHospital Anxiety and Depression Scale - Anxiety Scale at 12-months Follow-up8.00 units on a scaleStandard Deviation 3.7
Usual Cardiac Care - WomenHospital Anxiety and Depression Scale - Anxiety Scale at 12-months Follow-up7.25 units on a scaleStandard Deviation 3.57
Cognitive Therapy Group - MenHospital Anxiety and Depression Scale - Anxiety Scale at 12-months Follow-up4.43 units on a scaleStandard Deviation 3.77
Primary

Hospital Anxiety and Depression Scale - Anxiety Scale at 6-months Follow-up

Psychometric scale measuring symptoms of anxiety,score range is 0 to 24. Scores \>= 8 represent clinically elevated scores. Higher scores represent greater anxiety symptoms.

Time frame: Six-months follow-up

Population: Intention to treat analyses but data on participants who died over follow-up were omitted.

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenHospital Anxiety and Depression Scale - Anxiety Scale at 6-months Follow-up6.06 units on a scaleStandard Deviation 3.84
Cognitive Behaviour Therapy - WomenHospital Anxiety and Depression Scale - Anxiety Scale at 6-months Follow-up7.28 units on a scaleStandard Deviation 4.01
Usual Cardiac Care - WomenHospital Anxiety and Depression Scale - Anxiety Scale at 6-months Follow-up6.83 units on a scaleStandard Deviation 4.67
Cognitive Therapy Group - MenHospital Anxiety and Depression Scale - Anxiety Scale at 6-months Follow-up4.69 units on a scaleStandard Deviation 3.92
Primary

Hospital Anxiety and Depression Scale - Anxiety Scale at Baseline

Psychometric scale measuring symptoms of anxiety,score range is 0 to 24. Scores \>= 8 represent clinically elevated scores. Higher scores represent greater anxiety symptoms.

Time frame: Baseline

Population: Intention to treat analyses but data on participants who died over follow-up were omitted.

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenHospital Anxiety and Depression Scale - Anxiety Scale at Baseline6.53 units on a scaleStandard Deviation 4.26
Cognitive Behaviour Therapy - WomenHospital Anxiety and Depression Scale - Anxiety Scale at Baseline9.32 units on a scaleStandard Deviation 5.5
Usual Cardiac Care - WomenHospital Anxiety and Depression Scale - Anxiety Scale at Baseline7.70 units on a scaleStandard Deviation 3.85
Cognitive Therapy Group - MenHospital Anxiety and Depression Scale - Anxiety Scale at Baseline4.80 units on a scaleStandard Deviation 3.93
Primary

Hospital Anxiety and Depression Scale - Depression Scale at 12-months Follow-up

Psychometric scale measuring symptoms of depression, score range is 0 to 24. Scores \>= 8 represent clinically elevated scores. Higher scores represent greater depressive symptoms.

Time frame: Twelve-months follow-up

Population: Intention to treat analyses but data on participants who died over follow-up were omitted.

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenHospital Anxiety and Depression Scale - Depression Scale at 12-months Follow-up4.52 units on a scaleStandard Deviation 3.29
Cognitive Behaviour Therapy - WomenHospital Anxiety and Depression Scale - Depression Scale at 12-months Follow-up4.67 units on a scaleStandard Deviation 4.19
Usual Cardiac Care - WomenHospital Anxiety and Depression Scale - Depression Scale at 12-months Follow-up5.87 units on a scaleStandard Deviation 3.12
Cognitive Therapy Group - MenHospital Anxiety and Depression Scale - Depression Scale at 12-months Follow-up4.15 units on a scaleStandard Deviation 3.36
Primary

Hospital Anxiety and Depression Scale - Depression Scale at 6-months Follow-up

Psychometric scale measuring symptoms of depression, score range is 0 to 24. Scores \>= 8 represent clinically elevated scores. Higher scores represent greater depressive symptoms.

Time frame: Six-months follow-up

Population: Intention to treat analyses but data on participants who died over follow-up were omitted.

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenHospital Anxiety and Depression Scale - Depression Scale at 6-months Follow-up4.21 units on a scaleStandard Deviation 3.31
Cognitive Behaviour Therapy - WomenHospital Anxiety and Depression Scale - Depression Scale at 6-months Follow-up4.86 units on a scaleStandard Deviation 3.25
Usual Cardiac Care - WomenHospital Anxiety and Depression Scale - Depression Scale at 6-months Follow-up5.50 units on a scaleStandard Deviation 4.22
Cognitive Therapy Group - MenHospital Anxiety and Depression Scale - Depression Scale at 6-months Follow-up3.82 units on a scaleStandard Deviation 3.39
Primary

Hospital Anxiety and Depression Scale - Depression Scale at Baseline

Psychometric scale measuring symptoms of depression, score range is 0 to 24. Scores \>= 8 represent clinically elevated scores. Higher scores represent greater depressive symptoms.

Time frame: Baseline

Population: Intention to treat analyses but data on participants who died over follow-up were omitted.

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenHospital Anxiety and Depression Scale - Depression Scale at Baseline4.70 units on a scaleStandard Deviation 3.41
Cognitive Behaviour Therapy - WomenHospital Anxiety and Depression Scale - Depression Scale at Baseline7.47 units on a scaleStandard Deviation 5.02
Usual Cardiac Care - WomenHospital Anxiety and Depression Scale - Depression Scale at Baseline5.35 units on a scaleStandard Deviation 3.82
Cognitive Therapy Group - MenHospital Anxiety and Depression Scale - Depression Scale at Baseline4.12 units on a scaleStandard Deviation 4.01
Primary

Impact of Event Scale-Revised Hyperarousal Scale at 12-months Follow-up

Psychometric measure of post traumatic stress disorder hyper-arousal symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder hyperarousal symptoms.

Time frame: Twelve-months follow-up

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenImpact of Event Scale-Revised Hyperarousal Scale at 12-months Follow-up0.64 units on a scaleStandard Deviation 0.73
Cognitive Behaviour Therapy - WomenImpact of Event Scale-Revised Hyperarousal Scale at 12-months Follow-up0.57 units on a scaleStandard Deviation 0.54
Usual Cardiac Care - WomenImpact of Event Scale-Revised Hyperarousal Scale at 12-months Follow-up0.67 units on a scaleStandard Deviation 0.7
Cognitive Therapy Group - MenImpact of Event Scale-Revised Hyperarousal Scale at 12-months Follow-up0.39 units on a scaleStandard Deviation 0.43
Primary

Impact of Event Scale-Revised Hyperarousal Scale at 6-months Follow-up

Psychometric measure of post traumatic stress disorder hyper-arousal symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder hyperarousal symptoms.

Time frame: Six-months follow-up

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenImpact of Event Scale-Revised Hyperarousal Scale at 6-months Follow-up0.61 units on a scaleStandard Deviation 0.7
Cognitive Behaviour Therapy - WomenImpact of Event Scale-Revised Hyperarousal Scale at 6-months Follow-up0.64 units on a scaleStandard Deviation 0.87
Usual Cardiac Care - WomenImpact of Event Scale-Revised Hyperarousal Scale at 6-months Follow-up0.56 units on a scaleStandard Deviation 0.61
Cognitive Therapy Group - MenImpact of Event Scale-Revised Hyperarousal Scale at 6-months Follow-up0.52 units on a scaleStandard Deviation 0.7
Primary

Impact of Event Scale-Revised Hyperarousal Scale at Baseline

Psychometric measure of post traumatic stress disorder hyper-arousal symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder hyperarousal symptoms.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenImpact of Event Scale-Revised Hyperarousal Scale at Baseline0.78 units on a scaleStandard Deviation 0.86
Cognitive Behaviour Therapy - WomenImpact of Event Scale-Revised Hyperarousal Scale at Baseline1.40 units on a scaleStandard Deviation 1.11
Usual Cardiac Care - WomenImpact of Event Scale-Revised Hyperarousal Scale at Baseline1.07 units on a scaleStandard Deviation 0.98
Cognitive Therapy Group - MenImpact of Event Scale-Revised Hyperarousal Scale at Baseline0.64 units on a scaleStandard Deviation 0.67
Primary

Impact of Events Scale-Revised - Avoidance Scale at 12-months Follow-up

Psychometric assessment of post traumatic stress disorder avoidance symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder avoidance symptoms.

Time frame: Twelve-months follow-up

Population: Intention to treat analysis although data from participants who died were omitted from analysis

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenImpact of Events Scale-Revised - Avoidance Scale at 12-months Follow-up0.82 units on a scaleStandard Deviation 0.74
Cognitive Behaviour Therapy - WomenImpact of Events Scale-Revised - Avoidance Scale at 12-months Follow-up0.84 units on a scaleStandard Deviation 0.65
Usual Cardiac Care - WomenImpact of Events Scale-Revised - Avoidance Scale at 12-months Follow-up0.98 units on a scaleStandard Deviation 0.86
Cognitive Therapy Group - MenImpact of Events Scale-Revised - Avoidance Scale at 12-months Follow-up0.57 units on a scaleStandard Deviation 0.66
Primary

Impact of Events Scale-Revised - Avoidance Scale at 6-months Follow-up

Psychometric assessment of post traumatic stress disorder avoidance symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder avoidance symptoms.

Time frame: Six-months follow-up

Population: Intention to treat analysis although data from participants who died were omitted from analysis

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenImpact of Events Scale-Revised - Avoidance Scale at 6-months Follow-up0.86 units on a scaleStandard Deviation 0.64
Cognitive Behaviour Therapy - WomenImpact of Events Scale-Revised - Avoidance Scale at 6-months Follow-up0.77 units on a scaleStandard Deviation 0.87
Usual Cardiac Care - WomenImpact of Events Scale-Revised - Avoidance Scale at 6-months Follow-up0.74 units on a scaleStandard Deviation 0.71
Cognitive Therapy Group - MenImpact of Events Scale-Revised - Avoidance Scale at 6-months Follow-up0.55 units on a scaleStandard Deviation 0.64
Primary

Impact of Events Scale-Revised - Avoidance Scale at Baseline

Psychometric assessment of post traumatic stress disorder avoidance symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder avoidance symptoms.

Time frame: Baseline

Population: Intention to treat analysis although data from participants who died were omitted from analysis

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenImpact of Events Scale-Revised - Avoidance Scale at Baseline0.84 units on a scaleStandard Deviation 0.62
Cognitive Behaviour Therapy - WomenImpact of Events Scale-Revised - Avoidance Scale at Baseline1.68 units on a scaleStandard Deviation 1.1
Usual Cardiac Care - WomenImpact of Events Scale-Revised - Avoidance Scale at Baseline1.25 units on a scaleStandard Deviation 0.82
Cognitive Therapy Group - MenImpact of Events Scale-Revised - Avoidance Scale at Baseline0.64 units on a scaleStandard Deviation 0.58
Primary

Impact of Events Scale-Revised - Intrusiveness Scale at 12-months Follow-up

Psychometric measure of post traumatic stress disorder intrusiveness symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder intrusiveness symptoms.

Time frame: Twelve-months follow-up

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenImpact of Events Scale-Revised - Intrusiveness Scale at 12-months Follow-up0.62 units on a scaleStandard Deviation 0.62
Cognitive Behaviour Therapy - WomenImpact of Events Scale-Revised - Intrusiveness Scale at 12-months Follow-up0.64 units on a scaleStandard Deviation 0.6
Usual Cardiac Care - WomenImpact of Events Scale-Revised - Intrusiveness Scale at 12-months Follow-up0.80 units on a scaleStandard Deviation 0.7
Cognitive Therapy Group - MenImpact of Events Scale-Revised - Intrusiveness Scale at 12-months Follow-up0.42 units on a scaleStandard Deviation 0.47
Primary

Impact of Events Scale-Revised - Intrusiveness Scale at 6-months Follow-up

Psychometric measure of post traumatic stress disorder intrusiveness symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder intrusiveness symptoms.

Time frame: Six-months follow-up

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenImpact of Events Scale-Revised - Intrusiveness Scale at 6-months Follow-up0.61 units on a scaleStandard Deviation 0.52
Cognitive Behaviour Therapy - WomenImpact of Events Scale-Revised - Intrusiveness Scale at 6-months Follow-up0.82 units on a scaleStandard Deviation 0.96
Usual Cardiac Care - WomenImpact of Events Scale-Revised - Intrusiveness Scale at 6-months Follow-up0.73 units on a scaleStandard Deviation 0.73
Cognitive Therapy Group - MenImpact of Events Scale-Revised - Intrusiveness Scale at 6-months Follow-up0.56 units on a scaleStandard Deviation 0.73
Primary

Impact of Events Scale-Revised - Intrusiveness Scale at Baseline

Psychometric measure of post traumatic stress disorder intrusiveness symptoms, scores range from 0 to 4. Higher scores represent greater post traumatic stress disorder intrusiveness symptoms.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenImpact of Events Scale-Revised - Intrusiveness Scale at Baseline0.80 units on a scaleStandard Deviation 0.71
Cognitive Behaviour Therapy - WomenImpact of Events Scale-Revised - Intrusiveness Scale at Baseline1.53 units on a scaleStandard Deviation 0.98
Usual Cardiac Care - WomenImpact of Events Scale-Revised - Intrusiveness Scale at Baseline1.25 units on a scaleStandard Deviation 0.95
Cognitive Therapy Group - MenImpact of Events Scale-Revised - Intrusiveness Scale at Baseline0.61 units on a scaleStandard Deviation 0.64
Primary

Impact of Events Scale-Revised - Total Score at 12-months Follow-up

Psychometric measure of post traumatic stress disorder symptoms, scores range from 0 to 4. A score threshold of 1.4 has been found to diagnostic of post traumatic stress disorder in war veterans. Higher scores represent greater total post traumatic stress disorder symptoms.

Time frame: Twelve-months follow-up

Population: Intention to treat analysis although data for participants who died over follow-up were omitted.

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenImpact of Events Scale-Revised - Total Score at 12-months Follow-up0.70 units on a scaleStandard Deviation 0.64
Cognitive Behaviour Therapy - WomenImpact of Events Scale-Revised - Total Score at 12-months Follow-up0.69 units on a scaleStandard Deviation 0.53
Usual Cardiac Care - WomenImpact of Events Scale-Revised - Total Score at 12-months Follow-up0.82 units on a scaleStandard Deviation 0.69
Cognitive Therapy Group - MenImpact of Events Scale-Revised - Total Score at 12-months Follow-up0.46 units on a scaleStandard Deviation 0.47
Primary

Impact of Events Scale-Revised - Total Score at 6-months Follow-up

Psychometric measure of post traumatic stress disorder symptoms, scores range from 0 to 4. A score threshold of 1.4 has been found to diagnostic of post traumatic stress disorder in war veterans. Higher scores represent greater total post traumatic stress disorder symptoms.

Time frame: Six-months follow-up

Population: Intention to treat analysis although data for participants who died over follow-up were omitted.

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenImpact of Events Scale-Revised - Total Score at 6-months Follow-up0.70 units on a scaleStandard Deviation 0.52
Cognitive Behaviour Therapy - WomenImpact of Events Scale-Revised - Total Score at 6-months Follow-up0.76 units on a scaleStandard Deviation 0.83
Usual Cardiac Care - WomenImpact of Events Scale-Revised - Total Score at 6-months Follow-up0.68 units on a scaleStandard Deviation 0.64
Cognitive Therapy Group - MenImpact of Events Scale-Revised - Total Score at 6-months Follow-up0.54 units on a scaleStandard Deviation 0.62
Primary

Impact of Events Scale-Revised - Total Score at Baseline

Psychometric measure of post traumatic stress disorder symptoms, scores range from 0 to 4. A score threshold of 1.4 has been found to diagnostic of post traumatic stress disorder in war veterans. Higher scores represent greater total post traumatic stress disorder symptoms.

Time frame: Baseline

Population: Intention to treat analysis although data for participants who died over follow-up were omitted.

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenImpact of Events Scale-Revised - Total Score at Baseline0.81 units on a scaleStandard Deviation 0.66
Cognitive Behaviour Therapy - WomenImpact of Events Scale-Revised - Total Score at Baseline1.56 units on a scaleStandard Deviation 0.99
Usual Cardiac Care - WomenImpact of Events Scale-Revised - Total Score at Baseline1.20 units on a scaleStandard Deviation 0.85
Cognitive Therapy Group - MenImpact of Events Scale-Revised - Total Score at Baseline0.63 units on a scaleStandard Deviation 0.51
Secondary

Percentage of Participants Who Received ICD Therapies

Percentage of participants who received ICD shocks or anti-tachycardia therapies, data extracted from participants ICD devices over follow-up.

Time frame: 12-months follow-up

ArmMeasureValue (NUMBER)
Usual Cardiac Care - MenPercentage of Participants Who Received ICD Therapies30.5 Percentage of participants
Cognitive Behaviour Therapy - WomenPercentage of Participants Who Received ICD Therapies31.9 Percentage of participants
Secondary

SF-36 Mental Component Summary Scale at 12-months Follow-up

Quality of life measure - mental health summary, scores range from 0 to 100 with higher scores representing better mental health.

Time frame: Twelve-months follow-up

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenSF-36 Mental Component Summary Scale at 12-months Follow-up49.92 units on a scaleStandard Deviation 10.5
Cognitive Behaviour Therapy - WomenSF-36 Mental Component Summary Scale at 12-months Follow-up46.26 units on a scaleStandard Deviation 14
Usual Cardiac Care - WomenSF-36 Mental Component Summary Scale at 12-months Follow-up41.58 units on a scaleStandard Deviation 9.02
Cognitive Therapy Group - MenSF-36 Mental Component Summary Scale at 12-months Follow-up51.61 units on a scaleStandard Deviation 46.26
Secondary

SF-36 Mental Component Summary Scale at 6-months Follow-up

Quality of life measure - mental health summary, scores range from 0 to 100 with higher scores representing better mental health.

Time frame: Six-months follow-up

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenSF-36 Mental Component Summary Scale at 6-months Follow-up48.73 units on a scaleStandard Deviation 10.34
Cognitive Behaviour Therapy - WomenSF-36 Mental Component Summary Scale at 6-months Follow-up43.82 units on a scaleStandard Deviation 11.64
Usual Cardiac Care - WomenSF-36 Mental Component Summary Scale at 6-months Follow-up45.67 units on a scaleStandard Deviation 10.84
Cognitive Therapy Group - MenSF-36 Mental Component Summary Scale at 6-months Follow-up51.32 units on a scaleStandard Deviation 10.99
Secondary

SF-36 Mental Component Summary Scale at Baseline

Quality of life measure - mental health summary, scores range from 0 to 100 with higher scores representing better mental health.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenSF-36 Mental Component Summary Scale at Baseline45.90 units on a scaleStandard Deviation 13.4
Cognitive Behaviour Therapy - WomenSF-36 Mental Component Summary Scale at Baseline37.44 units on a scaleStandard Deviation 13.69
Usual Cardiac Care - WomenSF-36 Mental Component Summary Scale at Baseline42.33 units on a scaleStandard Deviation 12.43
Cognitive Therapy Group - MenSF-36 Mental Component Summary Scale at Baseline49.84 units on a scaleStandard Deviation 10.56
Secondary

SF-36 Physical Component Summary Score at 12-months Follow-up

Quality of life measure of physical health, scores range from 0 to 100 with higher scores representing better physical health.

Time frame: Twelve-months follow-up

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenSF-36 Physical Component Summary Score at 12-months Follow-up42.65 units on a scaleStandard Deviation 10.33
Cognitive Behaviour Therapy - WomenSF-36 Physical Component Summary Score at 12-months Follow-up42.70 units on a scaleStandard Deviation 10.44
Usual Cardiac Care - WomenSF-36 Physical Component Summary Score at 12-months Follow-up42.82 units on a scaleStandard Deviation 14.53
Cognitive Therapy Group - MenSF-36 Physical Component Summary Score at 12-months Follow-up41.54 units on a scaleStandard Deviation 11.23
Secondary

SF-36 Physical Component Summary Score at 6-months Follow-up

Quality of life measure of physical health, scores range from 0 to 100 with higher scores representing better physical health.

Time frame: Six-months follow-up

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenSF-36 Physical Component Summary Score at 6-months Follow-up42.54 units on a scaleStandard Deviation 10.58
Cognitive Behaviour Therapy - WomenSF-36 Physical Component Summary Score at 6-months Follow-up41.46 units on a scaleStandard Deviation 12.43
Usual Cardiac Care - WomenSF-36 Physical Component Summary Score at 6-months Follow-up41.22 units on a scaleStandard Deviation 12.85
Cognitive Therapy Group - MenSF-36 Physical Component Summary Score at 6-months Follow-up42.69 units on a scaleStandard Deviation 10.06
Secondary

SF-36 Physical Component Summary Score at Baseline

Quality of life measure of physical health, scores range from 0 to 100 with higher scores representing better physical health.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Usual Cardiac Care - MenSF-36 Physical Component Summary Score at Baseline39.19 units on a scaleStandard Deviation 10.46
Cognitive Behaviour Therapy - WomenSF-36 Physical Component Summary Score at Baseline36.13 units on a scaleStandard Deviation 7.06
Usual Cardiac Care - WomenSF-36 Physical Component Summary Score at Baseline37.60 units on a scaleStandard Deviation 11.81
Cognitive Therapy Group - MenSF-36 Physical Component Summary Score at Baseline38.85 units on a scaleStandard Deviation 10.15

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026